1 2 3 4 5

Characterization of ADME gene variation in 21 populations by exome sequencing

Hovelson, Daniel H.; Xue, Zhengyu; Zawistowski, Matthew; More

Pharmacogenetics and Genomics . 27(3):89-100, March 2017.

Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals

Lubomirov, Rubin; Arab-Alameddine, Mona; Rotger, Margalida; More

Pharmacogenetics and Genomics . 23(1):9-18, January 2013.

CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: a case–control study

Figueiras, Adolfo; Estany-Gestal, Ana; Aguirre, Carmelo; More

Pharmacogenetics and Genomics . 26(2):66-73, February 2016.

Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202

Verma, Anurag; Bradford, Yuki; Verma, Shefali S.; More

Pharmacogenetics and Genomics . 27(3):101-111, March 2017.

Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations: implications for clinical implementation of pharmacogenomics

Chan, Sze Ling; Samaranayake, Nilakshi; Ross, Colin J.D.; More

Pharmacogenetics and Genomics . 26(1):28-39, January 2016.

The common Arg389gly ADRB1 polymorphism affects heart rate response to the ultra-short-acting β1 adrenergic receptor antagonist esmolol in healthy individuals

Muszkat, Mordechai; Hoofien, Assaf; Orlanski-Meyer, Esther; More

Pharmacogenetics and Genomics . 23(1):25-28, January 2013.

CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals

Schmid, Yasmin; Vizeli, Patrick; Hysek, Cédric M.; More

Pharmacogenetics and Genomics . 26(8):397-401, August 2016.

A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration

Lorés-Motta, Laura; van Asten, Freekje; Muether, Philipp S.; More

Pharmacogenetics and Genomics . 26(1):20-27, January 2016.

Pharmacogenomic characterization of gemcitabine response – a framework for data integration to enable personalized medicine

Harris, Michael; Bhuvaneshwar, Krithika; Natarajan, Thanemozhi; More

Pharmacogenetics and Genomics . 24(2):81-93, February 2014.

Genome-wide analysis of clopidogrel active metabolite levels identifies novel variants that influence antiplatelet response

Backman, Joshua D.; O’Connell, Jeffrey R.; Tanner, Keith; More

Pharmacogenetics and Genomics . 27(4):159-163, April 2017.

Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case–control study

Hess, Mark W.; de Baaij, Jeroen H.F.; Broekman, Mark M.T.J.; More

Pharmacogenetics and Genomics . 27(3):83-88, March 2017.

The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response

Lewis, Joshua P.; Horenstein, Richard B.; Ryan, Kathleen; More

Pharmacogenetics and Genomics . 23(1):1-8, January 2013.

A novel ABCC6 haplotype is associated with azathioprine drug response in myasthenia gravis

Colleoni, Lara; Galbardi, Barbara; Barzago, Claudia; More

Pharmacogenetics and Genomics . 27(2):51-56, February 2017.

Influence of common polymorphisms in the SLC5A2 gene on metabolic traits in subjects at increased risk of diabetes and on response to empagliflozin treatment in patients with...

Zimdahl, Heike; Haupt, Axel; Brendel, Michael; More

Pharmacogenetics and Genomics . 27(4):135-142, April 2017.

1 2 3 4 5